维普期刊资源整合服务平台（V6.5）

114篇 您的检索式：作者名="HAURA"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer显示文摘	Brandon A. Howard Zhong Zheng Michael J. Campa Michael Z. Wang Anupama Sharma Eric Haura James E. Herndon Michael C. Fitzgerald Gerold Bepler Edward F. Patz	2004	Lung Cancer2004，，：	2
2	A phase I trial of the small molecule pan-bcl-2 inhibitor obatoclax (GX15-070) in combination with docetaxel in patients with relapsed nonsmall cell lung cancer (NSCLC)[Meeting Abstract]显示文摘	Haura E B Williams C A Chiappori A A		0，，15：	1
3	Pharmacogenomics strate- gies for developing customized chemotherapy in non-small cell lung cancer 显示文摘	Sarries C Haura EB Roig B	2002	Pharmacogenomics2002，3，6：	1
4	Mechanisms of disease:insights into the emerging role of signal transducers and activators of transcription in cancer显示文摘	Haura EB Turkson J Jove R	2005	Nat Clin Pract Oncol2005，2，：	1
5	Targeting epidermal growth factor receptor:central signaling kinase in lung cancer显示文摘	Yoshida T Zhang GL Haura EB		0，，05：	1
6	Mechanisms of disease : Insights into the emerging role of signal transducers and activators of transcription in cancer显示文摘	Haura EB Turkson J JoveR	2005	Nat Clin Pract Oncol2005，2，6：	1
7	Is repetitive wounding and bone marrow-derived stem cell mediated-repair an etiology of lung cancer development and dissemination 显示文摘	Haura Eric B	2006	Medical Hypotheses2006，67，4：	1
8	Polymorphisms of the DNA genes Erccl and lung cancer risk显示文摘	Sarries C Haura EB Roig B	2001	Cancer Epidemiol Biomark Prevent2001，10，2：	1
9	Src kinases as therapeutic targetsfor cancer 显示文摘	Kim LC Song L Haura EB	2009	Nat Rev Clin Oncol2009，6，10：	1
10	Phase I / II study of the Src inhibitor dasatinib in combination with er- lotinib in advanced non-small-cell lung cancer 显示文摘	Haura EB Tanvetyanon T Chiappori A	2010	J Clin On- col2010，28，8：	1
11	MCI-I is a survival factor in lung cancer显示文摘	ERIC B HAURA LANXI S	2003	Oral Sessions Prognostic Factor2003，8，：	1
12	Intranuclear Delivery of a Novel Antibody-Derived Radiosensitizer Targeting the DNA-Dependent Protein Kinase Catalytic Subunit显示文摘	Hairong Xiong Robert J. Lee Eric B. Haura John G. Edwards William S. Dynan Shuyi Li	2012	International Journal of Radiation Oncology Biology Physics2012，，3：	1
13	Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer 显示文摘	Haura EB Turkson J Jove R	2005	Nat Clin Pract Oncol2005，2，6：	1
14	Tranylcypromine plus risperidone for treatment-refractory depression显示文摘	Stoll AL Haura J	2000	J Clin Psyhopharmacol2000，20，4：	1
15	Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer显示文摘	Sanies C Haura E B Roig B	2002	Pharmacogenomics2002，3，6：	1
16	Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer显示文摘	Sarries C Haura EB Roig B	2002	Pharmacogenomics2002，3，6：	1
17	Non-canonical IKKs, IKKε and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer显示文摘	Jae-Young Kim Amer A Beg Eric B Haura	2013	Expert Opinion on Therapeutic Targets2013，，：	1
18	Src kinases as therapeutic targets for cancer显示文摘	Kim LC Song L Haura EB		0，，10：	1
19	Phase Ⅰ/Ⅱ study of atrasentan in combination with carboplatin and paclitaxel in chemonaive patients with advanced non-small-cell lung cancer (NSCLC) 显示文摘	Chiappori A Haura E Williams C	2005	Proe Am Soe Clin Oneol2005，24，64：	1
20	Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer显示文摘	SARRIES C HAURA E B ROIG B 1	2002	Pharmacogenornics2002，3，6：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示